scholarly journals ANAL FISTULA TREATED BY HOMEOPATHY IN A FRENCH BULLDOG - CASE REPORT

2021 ◽  
pp. 143-145
Author(s):  
Ana Catarina Viana Valle ◽  
Aloísio Cunha de Carvalho
Keyword(s):  
Side Effects ◽  
Anal Fistula ◽  
Treatment Time ◽  
Treatment Plan ◽  
Perianal Fistula ◽  
Small Animal ◽  
Natural Tendency ◽  
Clinical Changes ◽  
French Bulldog ◽  
German Physician

Introdution: Anal fistula/perianal is a disease that affects the anal tissue and adjacent skin, associated with severe skin infections. The occurrence of this disease is higher than it appears in the routine of the small animal clinic. The etiology of the perianal fistula has not been elucidated so far. The diagnosis is clinical, and its treatment employs antibiotics, immunosuppressants. However, these medicines are not always efficient, and surgery becomes the only option. Side effects are frequent, and a complementary treatment plan must be evaluated. Homeopathy is a therapeutic technique suggested by the German physician Samuel Hahnemann and aims at healing through stimuli to the body's vital energy. This study aimed to report a perianal fistula occurrence in a dog of the French bulldog breed treated by homeopathy. Methods: Male dog, French bulldog breed, with the complaint of walking and sitting at all times associated with the frequent licking of the anus. After physical examination the diagnosis was perianal fistula. The treatment was based by -9 -6 homeopathy with injectable medicines Belladonna D9 (1x10 ) associated with Arnica montana D6 (1x10 ); Nitric acidum -60 -18 30CH (1x10 ); Hamamellis virginiana D18 (1x10 ). The patient showed clinical improvement right after the first application of the medication, decreasing the stimulus of pain and discomfort. Seventeen days after treatment initiation, the inflammatory process was resolved. Homeopathy has been proposed as a regulatory therapy with a natural tendency to rebalance vital energy and organic functions. The homeopathic medicines were chosen based on the law of similars, i.e., using highly diluted and energized medicines to treat the symptoms and diseases that these same substances, in ponderal doses, would cause in a healthy patient. The treatment here reported did not generate side effects and was effective in its purpose. Treatment time was short, and, additionally, the animal was followed up for eight months after treatment with no relevant clinical changes. Conclusion: The therapeutic protocol determined reestablished the function of the affected tissues with total resolution of the disease in 17 days, with no complications. New comparative and randomized studies must be carried out to better understand the efficacy of such therapy

scholarly journals Subjective experience of electroconvulsive therapy

2004 ◽  
Vol 28 (8) ◽  
pp. 289-291 ◽  
Author(s):  
Susan M. Benbow ◽  
Joe Crentsil
Keyword(s):  
Side Effects ◽  
Electroconvulsive Therapy ◽  
Side Effect ◽  
Subjective Experience ◽  
Treatment Plan ◽  
Clinical Implications ◽  
Policies And Procedures ◽  
Routine Monitoring

Aims and MethodPeople receiving electroconvulsive therapy (ECT) in one clinic completed side-effect rating questionnaires during treatment, and a questionnaire rating their experience of different aspects of treatment on completion of the treatment course.ResultsSide-effects were commonly reported, but predominantly rated as mild or moderate. Most people reported that ECT had made them a little or a lot better, and that the treatment had been fairly or very well explained. Fewer than a fifth of respondents rated ECT as slightly or much worse than going to the dentist.Clinical ImplicationsWe recommend routine monitoring of the subjective experience of ECT, during treatment and on completion of the course. Ratings should inform the treatment plan, the policies and procedures of the ECT clinic.

scholarly journals Effectiveness and Tolerability of Methylphenidate in Children and Adolescents with Attention Deficit Hyperactivity Disorder

2011 ◽  
Vol 3 ◽  
pp. CMT.S6615
Author(s):  
Caroline Bodey
Keyword(s):  
Attention Deficit Hyperactivity Disorder ◽  
Side Effects ◽  
Children And Adolescents ◽  
Attention Deficit ◽  
Treatment Plan ◽  
Immediate Release ◽  
Height Velocity ◽  
Comprehensive Treatment ◽  
Hyperactivity Disorder ◽  
Cardiovascular Side Effects

Attention deficit hyperactivity disorder (ADHD) is a common condition and important for the affected individual, their family and society. It manifests with pervasive symptoms of hyperactivity, impulsivity and inattention. In many children with ADHD these symptoms persist into adolescence and adulthood. Drug treatment with psychostimulants, including methylphenidate, is an important part of a comprehensive treatment plan for children with severe ADHD that includes psychosocial, behavioural and educational advice and interventions. Methylphenidate is a central nervous system stimulant, whose mechanism of action is thought to be due to an increase in catecholamines in areas of the brain concerned with motivation and reward. Methylphendiate is available in short acting (immediate release) and longer acting (modified release) forms. Pharmacotherapy for ADHD is in three stages: initiation, maintenance and termination. The efficacy of methylphenidate in terms of reducing core symptoms is 70% as compared to placebo. This efficacy is maintained for at least 24 months. Methylphenidate generally has a favourable side effect profile. The most significant side effects include appetite suppression with an initial deceleration in height velocity, cardiovascular side effects that are not clinically significant in children with no adverse cardiac history, and tics. Methylphenidate is generally well tolerated and liked by children and adolescents with ADHD, who appreciate the benefits that medication has on their behaviour.

scholarly journals A Prediction Algorithm to Reduce Queuing Time using Parallel Patient Treatment Methodology

2018 ◽  
Vol 7 (3.12) ◽  
pp. 459
Author(s):  
John . ◽  
Vivia Mary ◽  
Gunda . ◽  
Rishik Reddy ◽  
Mullapudi . ◽  
...  
Keyword(s):  
Waiting Time ◽  
Real World ◽  
Large Scale ◽  
Treatment Time ◽  
Human Life ◽  
Treatment Plan ◽  
Prediction Algorithm ◽  
Patient Treatment ◽  
Efficient Treatment ◽  
Medical Institutions

Inefficient management of the patients’ queues is one of the major issues faced in medical institutions like clinics and hospitals which end up in creating large crowds at the hospital lobbies and an extended waiting time in the patients’ treatments. Waiting unnecessarily for a long period of time, ends only in loss or wastage of time, human life and hospital resources. It also increases the number or frustrated patients that are waiting to get treatment required. Every single patient has to undergo a diagnosis and then be forwarded to other departments or medical personnel for further procedures. Therefore, each patient’s waiting time is the time taken by the system to diagnose all the patients before him/her in the queue. In such a condition, the most practical decision would be to give out an efficient treatment plan to each patient. This can be implemented as a mobile application, wherein a predictable waiting time according to the diagnosis of the patient is uploaded, which then updates itself in real-time. Taking this into consideration, this paper proposes a Patient Treatment Time Prediction (PTTP) algorithm that can predict the time taken by a procedure for a particular patient. This algorithm can be applied to real-world scenarios and can be implemented in a large-scale environment. After predicting a treatment time necessary, the Hospital Queuing Recommendation (HQR) system can be developed. The job of calculating and predicting a convenient and an efficient treatment time for a particular patient can be done by the HQR system. The necessary input data for this is taken from a real world scenario like an actual doctor estimating time for a procedure at a particular hospital. This algorithm and system should work hand-in-hand generating responses of the utmost efficiency and very low latency. Once the model goes through extensive experimentation and simulation, an efficient model that demonstrates the effectiveness of this system can be recommended to other hospitals or medical institutions thus reducing waiting time per patient. 

scholarly journals RECHALLENGING TREATMENT PLAN FOR MULTIDRUG-RESISTANT TUBERCULOSIS IN DIABETIC PATIENT: A CASE REPORT

2019 ◽  
pp. 11-14 ◽  
Author(s):  
AHMED ALAA AL-TEMIMI ◽  
MUHAMMAD ZHARIF M NIZAM ◽  
YAHAYA HASSAN ◽  
NOORIZAN A AZIZ ◽  
MOHD FADLI MOHD ASMANI ◽  
...  
Keyword(s):  
Side Effect ◽  
Treatment Time ◽  
Treatment Plan ◽  
Multidrug Resistant ◽  
Prolonged Treatment ◽  
Development Of Resistance ◽  
Resistant Tuberculosis ◽  
Multidrug Resistant Tuberculosis ◽  
Mdr Tb ◽  
Hospital Acquired

Multidrug-resistant tuberculosis (MDR-TB) currently considers as the biggest issue and its subcategory, rifampicin-resistant TB (RR-TB). MDR-TB is defined as a resistant to isoniazid (H) and rifampicin (R), while the latter is resistant to rifampicin (R) only. Poorly controlled diabetes mellitus increases the risk of TB and leads to poor TB treatment outcomes as well it is consider potentially threating TB control. Difference in patients’ response and side effect developments toward anti-TB (ATB) medications requires rechallenging procedure that can be complicated at times. The management of MDR-TB can be complicated, especially, when the patient cannot tolerate the short regimen. Difference in patients’ response and side effect developments toward ATB medications requires rechallenging procedure which can have prolonged treatment time, hospital stay, and make patients exposed to hospital-acquired infection. This challenges and obstacles, however, could be prevented earlier by having strong DOTS strategy to prevent the development of resistance and reactivation of TB.

Standardizing risk: Development of disease and regimen-specific side effect language to enhance consent and chemotherapy treatment plan.

2014 ◽  
Vol 32 (30_suppl) ◽  
pp. 162-162
Author(s):  
Caitlin C. Donohue ◽  
Laura Perry ◽  
Sylvia Bartel ◽  
Aymen Elfiky ◽  
Marina Dusevic Kaymakcalan ◽  
...  
Keyword(s):  
Side Effects ◽  
Side Effect ◽  
Treatment Plan ◽  
Reading Level ◽  
Chemotherapy Treatment ◽  
Specific Language ◽  
Dana Farber Cancer Institute ◽  
American Society ◽  
Grade Reading Level ◽  
Multi Disciplinary Team

162 Background: The American Society of Clinical Oncology recommends the use of a synoptic Chemotherapy Treatment Plan (CTP) to define care including outlining anticipated side effects of chemotherapy. Dana-Farber Cancer Institute (DFCI) sought to improve their existing CTP template in the Electronic Medical Record (EMR) by standardizing side effect language. While DFCI’s existing CTP template contained a side effect section, it was burdensome, requiring clinicians to develop and list the risks for individual treatments. Side effect language varied in content and length, often inaccurately depicting the risks of treatment. DFCI created standardized, disease and regimen specific side effect templates, accessible within the EMR, in order to populate the side effects section of the CTP and consent. Methods: A multi-disciplinary team comprised of physicians, pharmacists, and administrators developed side effect language for chemotherapy regimens. Through research of published materials, a pharmacist wrote unique side effect language for each regimen, translated into a 6th grade reading level. The physicians reviewed the templates for accuracy and completeness making clinical edits to doses, schedules, and risks. Administrators assessed the language for readability using DFCI’s approved Risk Lay Language and built the side effect templates into the EMR. Clinicians access the templates in the CTP section of the EMR and populate the CTP with the appropriate disease and regimen-specific language. Results: There are 36 adult solid tumor disease categories at DFCI. Side effect profiles were developed for 27 (75%) of these categories. By fall 2014, 100% of the side effect profiles will be completed and available in the EMR. In total, 612 regimens will have specific side effect language written and built into the EMR as custom paragraphs. To date, 500 (82%) of the side effect profiles are in development. Conclusions: Building standardized disease and regimen specific side effect language provides patients and clinicians with an accurate depiction of the risks of treatment; subsequently ensuring proper patient education and elimination of provider documentation burden.

Clinical case: Gynecological side effects caused by methylphenidate

2017 ◽  
Vol 41 (S1) ◽  
pp. S430-S430
Author(s):  
A. Ballesteros ◽  
Á.S. Rosero ◽  
F. Inchausti ◽  
E. Manrique ◽  
H. Sáiz ◽  
...  
Keyword(s):  
Side Effects ◽  
Attention Deficit Disorder ◽  
Clinical Case ◽  
Case Reports ◽  
Treatment Plan ◽  
Complete Recovery ◽  
Current Evidence ◽  
Drug Discontinuation ◽  
Pubmed Search ◽  
Competing Interest

IntroductionMethylphenidate drugs is prescribed in attention deficit disorder and hyperactivity. Among its rare side effects, include alterations in the gynecological. We report a clinical case and review current evidence regarding the tolerability this drug in this area.MethodsWe performed a PubMed search of articles published in English of different types (case reports or case/controls studies). We collected the clinical practice guidelines conclusions regarding adverse drug reactions.Case presentationOur patient is a 14-year-old male diagnosed of ADHD treated with methylphenidate (0.8–1 mg\kg). He developed bilateral and asymmetric gynecomastia under this treatment plan so a referral was made to rule out other causes of this event. After performing several work up tests, it was concluded that this clinical presentation was caused by methylphenidate. Hence, we initiated crossed titration swapping this drug to atomoxetine. Four months later, he was mentally stable and he experimented a volumetric decrease as concerns his gynecomastia.As regards methylphenidate, in 2009 a couple of cases in which alterations in the sexual sphere presented with the oros presentation were reported. There are series of reported pharmacological side effects (gynecomastia) and also denoted an improvement of the same months after drug discontinuation.ConclusionsGynecological clinic secondary to the use of psychotropic drugs in ADHD is uncommon. In line with our case, the current evidence suggests a drug suspension as adverse effects are usually reversible (although it may take several months to complete recovery). Further studies are needed to understand the mechanisms underlying these tolerability issues.Disclosure of interestThe authors have not supplied their declaration of competing interest.

scholarly journals Factors affecting orthodontic treatment time and how to predict it

2021 ◽  
Author(s):  
Rania Adel Mitwally ◽  
Laila Marzooq Alesawi ◽  
Adhwaa Yahya Humedi ◽  
Saleh Saeed Al Baaltahin ◽  
Yara Ahmed Saeedi ◽  
...  
Keyword(s):  
Treatment Duration ◽  
Orthodontic Treatment ◽  
Treatment Time ◽  
Treatment Plan ◽  
Prolonged Treatment ◽  
Large Set ◽  
Factors Affecting ◽  
Underlying Condition ◽  
Level Of Satisfaction ◽  
Speed Up

Orthodontic treatment time has been associated with certain parameters that can affect the different aspects of treatment regards to the patient and orthodontist. Therefore, a large set of research has focused on studying these factors. Many factors have been proposed in the literature as significant predictors for prolonged orthodontic treatment duration. In general, these factors are related to the patient, orthodontist, procedure, and severity of the underlying condition. Acquiring more knowledge about these factors can help orthodontists speed up the treatment plan, which might enhance the treatment outcomes and enhance the levels of satisfaction. In the current study, we have provided updated evidence regarding the different factors affecting orthodontic treatment time according to evidence from studies in the literature. Many factors were reported, including factors related to the procedure and the underlying condition, and factors related to the patient and orthodontist. Increasing knowledge and experience of the orthodontist might increase the level of satisfaction as it has been reported to significantly reduce the treatment duration. However, this should be accompanied by adequate patient compliance, which was also reported to be a significant predictor for prolonged treatment duration. Investigating the application of recent modalities that can speed up the treatment plan is not adequately validated, indicating the need for future validating studies.

scholarly journals Study the Role of Loose versus cutting of Seton in Treatment of High Perianal fistula in a District Hospital of Health Insurance

QJM ◽  
2020 ◽  
Vol 113 (Supplement_1) ◽  
Author(s):  
M S Abdelhameed ◽  
I M H Elghazawy ◽  
E A Elsayed
Keyword(s):  
Anal Fistula ◽  
Low Cost ◽  
Perianal Fistula ◽  
Dentate Line ◽  
Internal Opening ◽  
Fistula In Ano ◽  
One Year ◽  
Definition Of ◽  
A Prospective Study ◽  
High Perianal Fistula

Abstract When the track reaches the skin or another epithelialized surface then a fistula is formed. Anal fistula were classified on the basis of its relationship to the sphincters. The definition of high or low describes the height of the track as it traverses the sphincter muscles and not the position of the internal opening which is almost without exception at the dentate line. More accurately according to parks classification fistula in ano can result in an abscess between the internal and external sphincters, which in turn can spread to other parts of the perianal region. Infection can then track in many directions from this focus in the intersphincteric plane. Background Anal fistula is an abnormal communicative small channel that has an internal opening and an external opening and connected by the primary track. Our study evaluate the effectiveness of seton in high variety anal fistula. Objectives Evaluation the efficacy and safety of seton as surgical management of high anal fistula. Methods: This is a prospective study done on 30 patients in ELNile hospital in one Year period with high variety of anal fistula which is above the dentate line and were treated with seton .Outcome measured during follow up period were- successfully healed, recurrence, incontinence, percentage of complications and patients satisfaction. Result Among 30 patients mean age was 42.2+_6.8 years. Overall outcome of the patients showed-fistula completely healed in 27 patients, incontinence occurred in 3 patients and recurrence occurred in 3 patients. Conclusion Seton is relatively safe, effective and low cost for the management of high anal fistula with low rate of incontinence. It can therefore, be recommended as the standard of treatment for high variety fistula in ano.

Sign in / Sign up

Export Citation Format

Share Document